Floatz logo

Lipitor

Hypercholesterolemia

Punjab Institute of CardologyPhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Hypercholesterolemia cohort.

Asset / SponsorPhaseRating
Ezetimibe
Punjab Institute of Cardology
Phase 4BBB
SIMVASTATIN
paresh Dandona
Phase 4BBB
PITAVASTATIN
JW Pharmaceutical
Phase 4BBB
PRAVASTATIN
Yokohama City University Medical Center
Phase 4BB
Rosuvastatin
Sanofi
Phase 4BB

View all 36 →

Same molecule, other indications

Lipitor is also rated in:

inherited lipid metabolism disorderDormant
A
Indicative ·
83 / 100
View asset →
hyperlipidemiaDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →